In both current studies, the safety data with cagrilintide were consistent with data from previous studies with no new safety or tolerability issues observed [4, 7, 10]
Gallbladder disease (including cholelithiasis and cholecystitis) has been reported in patients taking GLP-1 receptor agonists, particularly in the context of rapid weight loss
Clinical studies show a substantial 14.9% to 17.4% body weight reduction over 68 weeks with Wegovy, outperforming diet and exercise alone
It slows gastric emptying, fostering satisfaction with smaller meals, while also inhibiting hunger signals at the brain level
If you are considering GFC treatment or QR678 treatment for hair loss, one of the first questions that comes up is simple
TMAO formation: Carnitine can be metabolised into TMAOa compound linked to cardiovascular risk in observational research